Prognose des europäischen Marktes für Myopiebehandlungen bis 2030 – Regionale Analyse – nach Typ (starke Myopie, degenerative Myopie und progressive Myopie), Behandlung [niedrig dosierte Atropin-Augentropfen, Kontaktlinsen, Ortho-K und refraktive Chirurgie (LASIK, PRK)], Altersgruppe (Myopie bei Erwachsenen und Myopie bei Kindern) und Endverbraucher (Krankenhäuser und Kliniken, Fachkliniken und Zentren für refraktive Chirurgie)
Erhöhtes Bewusstsein für Myopiebehandlungen treibt europäischen Markt für Myopiebehandlungen an
Das gesteigerte Bewusstsein für Myopiebehandlungsoptionen treibt das beträchtliche Wachstum des Myopiebehandlungsmarktes an. Eine aktuelle Marktanalyse ergab, dass das zunehmende Bewusstsein für Myopiemanagementstrategien, insbesondere unter Eltern und Augenärzten, zu einem deutlichen Anstieg der Umsetzung von Myopiekontrollmaßnahmen geführt hat. Der weltweit führende Anbieter von Augenpflegeprodukten arbeitet mit drei der besten Optometrieschulen des Landes zusammen, um einer Pilotgruppe ab 2024 eine erweiterte Myopietherapie anzubieten. Da Sensibilisierungskampagnen, Bildungsinitiativen und umfangreiche Forschungsstudien weiterhin Licht auf die möglichen Folgen einer nicht behandelten Myopie werfen, ist eine deutliche Verschiebung hin zu proaktiven Myopiemanagementansätzen zu verzeichnen. Dieser Trend hat die Einführung von Myopiebehandlungstechnologien wie Orthokeratologie und pharmazeutischen Eingriffen gefördert, was zu einem bemerkenswerten Anstieg des Marktes geführt hat, der in den letzten zwei Jahren um über 25 % gewachsen ist. Die gemeinsamen Bemühungen, das Bewusstsein für Myopie als Problem der öffentlichen Gesundheit zu schärfen und die Realisierbarkeit von Myopiemanagementlösungen zu fördern, treiben das Marktwachstum voran und fördern eine Kultur der proaktiven Sehpflege. Diese Dynamik wird wahrscheinlich auch weiterhin Fortschritte bei der Myopiebehandlung vorantreiben und die zentrale Rolle des Bewusstseins bei der Gestaltung der Landschaft der Myopiemanagement- und -behandlungsstrategien betonen.
Überblick über den europäischen Markt für Myopiebehandlungen
Der europäische Markt für Myopiebehandlungen umfasst die konsolidierten Märkte für Deutschland, Frankreich, Großbritannien, Spanien, Italien und den Rest Europas. Europa nimmt auf dem globalen Markt für Myopiebehandlungen eine bedeutende Position ein und wird im Prognosezeitraum voraussichtlich eine robuste Wachstumsrate verzeichnen. Das Marktwachstum in der Region wird aufgrund der zunehmenden geriatrischen Bevölkerung, der zunehmenden Betonung der vorbeugenden Pflege in Europa und der steigenden Anzahl von Produkteinführungen in der Region erwartet. Die stark zunehmende geriatrische Bevölkerung Deutschlands stellt eine lukrative Gelegenheit für eine verstärkte Einführung von Nahrungsergänzungsmitteln für die Augengesundheit im Land dar. Laut „World Population Ageing 2017“ waren 2017 etwa 28 % der Gesamtbevölkerung Deutschlands 60 Jahre oder älter, und dieser Anteil wird bis zum Jahr 2050 auf fast 37,6 % steigen. Es wird auch erwähnt, dass die Lebenserwartung für Frauen auf 83 Jahre und für Männer auf 78 Jahre geschätzt wird. Diese höhere Lebenserwartung wird sich wahrscheinlich auf die Augengesundheit auswirken und letztendlich den deutschen Markt für Myopiebehandlungen im Prognosezeitraum antreiben.
Umsatz und Prognose des europäischen Marktes für Myopiebehandlungen bis 2030 (in Mio. USD)
Segmentierung des europäischen Marktes für Myopiebehandlungen
Der europäische Markt für Myopiebehandlungen ist nach Typ, Behandlung, Altersgruppe, Endbenutzer und Land kategorisiert.
Basierend auf dem Typ ist der europäische Markt für Myopiebehandlungen in starke Myopie, degenerative Myopie und progressive Myopie segmentiert. Das Segment starke Myopie hatte 2022 den größten Marktanteil an der Myopiebehandlung in Europa.
In Bezug auf die Behandlung ist der europäische Markt für Myopiebehandlungen in niedrig dosierte Atropin-Augentropfen, Kontaktlinsen, Ortho-K und refraktive Chirurgie segmentiert. Das Segment der niedrig dosierten Atropin-Augentropfen hatte 2022 den größten Marktanteil an der Myopiebehandlung in Europa. Darüber hinaus ist das Segment der refraktiven Chirurgie in LASIK und PRK unterteilt.
Nach Altersgruppen ist der europäische Markt für Myopiebehandlungen in Myopie bei Erwachsenen und Myopie bei Kindern unterteilt. Das Segment Myopie bei Erwachsenen hatte 2022 einen größeren Marktanteil an Myopiebehandlungen in Europa.
Basierend auf dem Endverbraucher ist der europäische Markt für Myopiebehandlungen in Krankenhäuser und Kliniken, Fachkliniken und Zentren für refraktive Chirurgie unterteilt. Das Segment Krankenhäuser und Kliniken hatte 2022 den größten Marktanteil an Myopiebehandlungen in Europa.
Nach Ländern ist der europäische Markt für Myopiebehandlungen in Deutschland, Großbritannien, Italien, Frankreich, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2022 den Marktanteil an Myopiebehandlungen in Europa.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Eyes Vision SL, Haag-Streit AG, Johnson & Johnson Vision Care Inc, Nidek Co Ltd und Ziemer Ophthalmic Systems AG gehören zu den führenden Unternehmen auf dem europäischen Markt für Myopiebehandlungen.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Myopia Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies
5. Europe Myopia Treatment Market - Key Market Dynamics
5.1 Europe Myopia Treatment Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Myopia
5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
5.5 Future Trends
5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:
6. Myopia Treatment Market - Europe Market Analysis
7. Europe Myopia Treatment Market Analysis - by Type
7.1 High Myopia
7.1.1 Overview
7.1.2 High Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
7.2.1 Overview
7.2.2 Degenerative Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
7.3.1 Overview
7.3.2 Progressive Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Myopia Treatment Market Analysis - by Treatment
8.1 Low-Dose Atropine Eye Drops
8.1.1 Overview
8.1.2 Low-Dose Atropine Eye Drops: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
8.2.1 Overview
8.2.2 Refractive Surgery: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2.3 LASIK
8.2.4 PRK
8.3 Contact Lenses
8.3.1 Overview
8.3.2 Contact Lenses: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
8.4.1 Overview
8.4.2 Ortho-K: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Myopia Treatment Market Analysis - by Age Group
9.1 Adult Myopia
9.1.1 Overview
9.1.2 Adult Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
9.2.1 Overview
9.2.2 Childhood Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Myopia Treatment Market Analysis - by End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
10.2.1 Overview
10.2.2 Specialty Clinics: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
10.3.1 Overview
10.3.2 Refractive Surgery Centers: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Myopia Treatment Market - Country Analysis
11.1 Europe
11.1.1 Europe: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
11.1.1.1 Europe: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
11.1.1.2 Germany
11.1.1.3 Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Germany: Myopia Treatment Market Breakdown, by Type
11.1.1.3.2 Germany: Myopia Treatment Market Breakdown, by Treatment
11.1.1.3.3 Germany: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.3.4 Germany: Myopia Treatment Market Breakdown, by Age Group
11.1.1.3.5 Germany: Myopia Treatment Market Breakdown, by End User
11.1.1.4 France
11.1.1.5 France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 France: Myopia Treatment Market Breakdown, by Type
11.1.1.5.2 France: Myopia Treatment Market Breakdown, by Treatment
11.1.1.5.3 France: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.5.4 France: Myopia Treatment Market Breakdown, by Age Group
11.1.1.5.5 France: Myopia Treatment Market Breakdown, by End User
11.1.1.6 UK
11.1.1.7 UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.7.1 UK: Myopia Treatment Market Breakdown, by Type
11.1.1.7.2 UK: Myopia Treatment Market Breakdown, by Treatment
11.1.1.7.3 UK: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.7.4 UK: Myopia Treatment Market Breakdown, by Age Group
11.1.1.7.5 UK: Myopia Treatment Market Breakdown, by End User
11.1.1.8 Italy
11.1.1.9 Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.9.1 Italy: Myopia Treatment Market Breakdown, by Type
11.1.1.9.2 Italy: Myopia Treatment Market Breakdown, by Treatment
11.1.1.9.3 Italy: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.9.4 Italy: Myopia Treatment Market Breakdown, by Age Group
11.1.1.9.5 Italy: Myopia Treatment Market Breakdown, by End User
11.1.1.10 Spain
11.1.1.11 Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.11.1 Spain: Myopia Treatment Market Breakdown, by Type
11.1.1.11.2 Spain: Myopia Treatment Market Breakdown, by Treatment
11.1.1.11.3 Spain: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.11.4 Spain: Myopia Treatment Market Breakdown, by Age Group
11.1.1.11.5 Spain: Myopia Treatment Market Breakdown, by End User
11.1.1.12 Rest of Europe
11.1.1.13 Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.13.1 Rest of Europe: Myopia Treatment Market Breakdown, by Type
11.1.1.13.2 Rest of Europe: Myopia Treatment Market Breakdown, by Treatment
11.1.1.13.3 Rest of Europe: Myopia Treatment Market Breakdown, by Refractive Surgery
11.1.1.13.4 Rest of Europe: Myopia Treatment Market Breakdown, by Age Group
11.1.1.13.5 Rest of Europe: Myopia Treatment Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Bausch Health Companies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CooperVision Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ziemer Ophthalmic Systems AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Nidek Co Ltd
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Eyes Vision SL
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Haag-Streit AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Carl Zeiss AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
List of Tables
Table 1. Europe Myopia Treatment Market Segmentation
Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
Table 3. Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 4. Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 5. Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 6. Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 7. Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 8. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 9. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 10. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 11. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 12. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 14. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 15. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 16. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 17. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 18. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 19. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 20. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 21. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 22. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 23. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 24. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 25. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 26. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 27. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 28. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 29. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 30. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 31. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 32. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 33. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 34. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
Table 35. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
Table 36. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
Table 37. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 38. Recent Organic Growth Strategies in Myopia Treatment Market
Table 39. Recent Inorganic Growth Strategies in the Myopia Treatment Market
Table 40. Glossary of Terms, Myopia Treatment Market
List of Figures
Figure 1. Europe Myopia Treatment Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Myopia Treatment Market Revenue (US$ Million), 2020-2030
Figure 5. Europe Myopia Treatment Market Share (%) - by Type (2022 and 2030)
Figure 6. High Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Degenerative Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Progressive Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
Figure 10. Low-Dose Atropine Eye Drops: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Refractive Surgery: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. LASIK: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. PRK: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Contact Lenses: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ortho-K: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
Figure 17. Adult Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Childhood Myopia: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Myopia Treatment Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Refractive Surgery Centers: Europe Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. Germany: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. France: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. UK: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Italy: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Spain: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Rest of Europe: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Growth Strategies in Myopia Treatment Market
1. Alcon AG
2. Bausch Health Companies Inc
3. Carl Zeiss AG
4. CooperVision Inc
5. Eyes Vision SL
6. Haag-Streit AG
7. Johnson & Johnson Vision Care Inc
8. Nidek Co Ltd
9. Ziemer Ophthalmic Systems AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe myopia treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe myopia treatment market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe myopia treatment market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.